A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck.
about
Evolving Evidence of the Efficacy and Safety of nab-Paclitaxel in the Treatment of Cancers with Squamous HistologiesPhase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer.Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neckPhase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).Cetuximab: its unique place in head and neck cancer treatmentnab-Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma.Effectiveness of incorporating cetuximab into docetaxel/cisplatin/fluorouracil induction chemotherapy and chemoradiotherapy for inoperable squamous cell carcinoma of the oral cavity: A phase II study.Correlation of Ki-67 Proliferative Antigen Expression and Tumor Response to Induction Chemotherapy Containing Cell Cycle-Specific Agents in Head and Neck Squamous Cell Carcinoma.Clinical benefit of nanoparticle albumin-bound-paclitaxel in recurrent/metastatic head and neck squamous cell carcinoma resistant to cremophor-based paclitaxel or docetaxel.
P2860
Q26766254-2676D743-6A12-4538-8538-326CE577B28DQ34754728-6B02D21B-C690-4ECD-877E-7031F0FC5857Q35469234-8C51A122-CFC2-4D3F-8A8A-0BAA799A9B75Q35611873-D9012F13-7293-4F69-969A-FF7E3C718DA1Q36880604-EA62EC0F-0E27-4108-9ABD-8559DF5C00E9Q40559372-F090BF1E-6130-4335-A0B3-1DD754C9F30BQ47926809-41843DBD-3DCE-4932-9562-EF4A3631A876Q49765539-82C3168E-1EC2-41F5-9012-757D82A84CC7Q50957199-09D7521A-46B8-4184-AB1B-D45F5A065BE4
P2860
A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase 2 trial of induction n ...... arcinoma of the head and neck.
@en
A phase 2 trial of induction n ...... arcinoma of the head and neck.
@nl
type
label
A phase 2 trial of induction n ...... arcinoma of the head and neck.
@en
A phase 2 trial of induction n ...... arcinoma of the head and neck.
@nl
prefLabel
A phase 2 trial of induction n ...... arcinoma of the head and neck.
@en
A phase 2 trial of induction n ...... arcinoma of the head and neck.
@nl
P2093
P2860
P356
P1433
P1476
A phase 2 trial of induction n ...... carcinoma of the head and neck
@en
P2093
Barry A Siegel
Brian Nussenbaum
Douglas Adkins
Farrokh Dehdashti
James Lewis
Jessica Ley
Kathryn Trinkaus
Paul Mehan
Tanya Wildes
Wade Thorstad
P2860
P304
P356
10.1002/CNCR.27741
P407
P50
P577
2012-09-18T00:00:00Z